NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed for two decades Business live – latest updates The boss of AstraZeneca has said that unless the UK ramps up spending on new drugs, it could be on a trajectory to only being able to afford cheap, generic medicines (…)
Site référencé:
The Guardian (South&CentralAsia)
5413.jpg?width=140&quality=85&auto=format&fit=max&s=7e243059ae2ace21bbd25679f1a8e314, 5413.jpg?width=460&quality=85&auto=format&fit=max&s=698d170124b9c9a17f51cab99e3a6dc2, 5413.jpg?width=700&quality=85&auto=format&fit=max&s=57ad5df4e5c394a098bfc5a949ed579c
The Guardian (South&CentralAsia)
Zohran Mamdani's biggest threat is not Donald Trump, it's the Democratic old guard | Emma Brockes
6/11/2025
Train Dreams review – Joel Edgerton superb in Malickian story of trees, grief and railroads
6/11/2025
Inquest finds German backpacker Simone Strobel killed by homicide - but can’t say who attacker was
6/11/2025
Death by Lightning review – absolutely nobody plays losers like Matthew Macfadyen
6/11/2025
How Tesla shareholders could make Elon Musk the world’s first trillionaire
6/11/2025
You be the judge : should my best friend stop calling me by a nickname ?
6/11/2025